Caricamento...
MNGI-06. EFFICACY OF (177)LU-DOTATATE THERAPY IN RECURRENT ANAPLASTIC MENINGIOMA
BACKGROUND: (177)Lu-Dotatate ((177)Lu-DOTA(0)-Tyr(3)-Octreotate) is a beta-particle emitting somatostatin analog recently FDA approved for the treatment of somastatin receptor-positive gastroenteropancreatic neuroendocrine tumors. Somatostatin receptors are highly expressed in almost all meningiomas...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6846959/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.588 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|